Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Exact Sciences Corp - SIC # 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
EXAS
Nasdaq
2835
https://www.exactsciences.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Exact Sciences Corp
Techne (TECH) Q3 Earnings and Revenues Beat Estimates
- May 1st, 2024 11:40 am
Exact Sciences to Participate in May Investor Conference
- May 1st, 2024 10:00 am
Exact Sciences (EXAS) Stock Drops Despite Market Gains: Important Facts to Note
- Apr 24th, 2024 10:15 pm
Here’s Why Baron Health Care Fund Reduced Exact Sciences Corporation (EXAS)
- Apr 24th, 2024 11:16 am
Should You Buy Exact Sciences (EXAS) Ahead of Q1 Earnings?
- Apr 22nd, 2024 4:44 pm
10 Best Performing Biotech ETFs in 2024
- Apr 22nd, 2024 3:10 pm
Why Exact Sciences (EXAS) Dipped More Than Broader Market Today
- Apr 17th, 2024 10:15 pm
Exact Sciences Corporation's (NASDAQ:EXAS) Profit Outlook
- Apr 17th, 2024 3:07 pm
Exact Sciences names Aaron Bloomer CFO
- Apr 15th, 2024 10:52 am
Exact Sciences Names Aaron Bloomer as New Chief Financial Officer
- Apr 15th, 2024 10:00 am
Here’s Why Exact Sciences Corporation (EXAS) Declined in Q1
- Apr 12th, 2024 11:00 am
Myriad Genetics (MYGN) Announces Favorable Research Results
- Apr 11th, 2024 2:00 pm
Zacks Investment Ideas feature highlights: Exact Sciences, Kaiser Aluminum and Atmus Filtration Technologies
- Apr 11th, 2024 11:52 am
Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes
- Apr 11th, 2024 10:00 am
Exact Sciences (EXAS) Stock Moves -0.89%: What You Should Know
- Apr 10th, 2024 10:15 pm
3 Buy-Rated Stocks Flexing Relative Strength
- Apr 10th, 2024 7:27 pm
Search for Cancer Blood Test Continues Despite Illumina-Grail Deal’s Failure
- Apr 10th, 2024 12:16 pm
ZTS, EXAS, AZN: Which Biotech Stock Is the Better Buy?
- Apr 10th, 2024 4:00 am
11 Best Biotech ETFs To Buy
- Apr 9th, 2024 11:37 am
Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024
- Apr 8th, 2024 4:05 pm
Scroll